Buruli ulcer

Buruli ulcer research

Tim Stinear
Overview of the proposed pathway for the production of mycolactones by Mycobacterium ulcerans.

Research priorities & news


Among the many potentially important areas of research on Buruli ulcer, six priority areas were selected by the research subgroup at the 5th WHO Advisory Group Meeting on Buruli Ulcer.
Read more

Buruli ulcer clinical trial

The ultimate goal is to search for an effective oral treatment to the current standard WHO-recommended therapy for all forms of Buruli ulcer, which includes injections of streptomycin.

Research consortia

Research network

The following institutions are involved in Buruli ulcer research activities:

Buruli in the news!

31 July 2014 | Geneva
Simple test promises early diagnosis of debilitating skin disease

10 July 2014 | Geneva
Clinical epidemiology of laboratory-confi rmed Buruli ulcer in Benin: a cohort
The Lancet , Vol 2 July 2014

20 June 2014 | Geneva
Management of BU–HIV co-infection
Tropical Medicine & International Health, DOI: 10.1111/tmi.12342

18 June 2014 | Geneva
Good data collection is essential for a better understanding of Buruli ulcer
The Lancet Global health, Vol 2, Issue 7

02 January 2014 | Geneva
Accelerated Detection of Mycolactone Production and Response to Antibiotic Treatment in a Mouse Model of Mycobacterium ulcerans Disease.
PloSntds DOI: 10.1371/journal.pntd.0002618


Laboratory confirmation
Guidance on sampling techniques for laboratory-confirmation of Mycobacterium ulcerans infection (Buruli ulcer disease)